Liposomal Bupivacaine in Total Shoulder Arthroplasty
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. All adult
patients over eighteen desiring shoulder arthroplasty will be eligible. The study compares
pain control and opioid consumption in patients undergoing shoulder arthroplasty between
patients receiving liposomal bupivacaine and those who underwent a preoperative inter-scalene
nerve block.